Innovation is one of the strategic and fundamental Biokit pillars
Biokit innovates at all levels: with regard to biomaterials, assays, and manufacturing biotechnology processes.
Open innovation is not a new concept for Biokit; from the 80s onwards Biokit has been collaborating with prestigious universities, research centres and companies around the world to constantly offer the most advanced solutions.
Innovation in Assays
Assay Innovation includes design of prototypes and Proof-of-Concept evaluation to verify biomaterials and reagent formulation for new immunoassays.